The trial showcased the continued efficacy of apremilast, with 2-year data on the forefront.
Shauna Jardon, PharmD
Advertisement
Articles by Shauna Jardon, PharmD
Advertisement
Latest Updated Articles
SPROUT Trial Highlights Benefits of Apremilast for Pediatric PsoriasisPublished: September 12th 2024 | Updated:
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
3
FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA
4
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
5